Ausamics IverPure™
High-Purity Research Compound – ≥95.8% Purity
No Additives. No Fillers. Trusted by Professionals.
Product Summary
Ausamics IverPure™ is a research-grade compound structurally related to ivermectin (CAS 70288-86-7), produced via fermentation of Streptomyces avermitilis. It contains approximately 80% 22,23-dihydroavermectin B1a and 20% B1b, and is supplied as a white to off-white crystalline powder.
This macrocyclic lactone is widely studied for its interaction with glutamate-gated chloride channels in invertebrate nerve and muscle cells. It is intended strictly for laboratory research and is not approved for therapeutic or veterinary use.
Product Details
| Attribute | Value |
|---|---|
| Catalog No. | AC-2050 |
| CAS Number | 70288-86-7 |
| Purity | ≥95.8% |
| Form | Crystalline powder |
| Color | White to off-white |
| Molecular Formula | C₄₈H₇₄O₁₄ |
| Molecular Weight | 875.10 g/mol |
Research Applications
Mechanistic studies of antiparasitic activity
Glutamate-gated ion channel modulation
Veterinary drug resistance research
Comparative studies in macrocyclic lactones
In vitro screening in parasitology and pharmacology
Storage & Handling
Store at 2–8°C in a tightly sealed container. Protect from moisture and direct light. Handle in accordance with standard laboratory safety protocols.
Regulatory Notice
This compound is classified as a Schedule 4 substance under the Australian Poisons Standard. It is not listed on the Australian Register of Therapeutic Goods (ARTG) and is not approved for human or veterinary administration.
If the “Order Qty” field is disabled, please contact us with your license or exemption documentation: 📞 +61 412 520 598 📧 sales@ausamics.com
Compliance Statement
Ausamics IverPure™ is sold strictly for laboratory research use only. It is not intended for therapeutic, diagnostic, agricultural, or human consumption. Buyers are responsible for ensuring compliance with all applicable local, state, and federal regulations.
International customers must confirm import eligibility with their local customs and regulatory authorities. Ausamics does not support or facilitate off-label or unauthorized applications.
Legal Disclaimer
Ausamics Pty Ltd reserves the right to refuse sale where regulatory compliance cannot be verified. All product descriptions are for informational purposes only and do not constitute endorsement of any specific use.
Ausamics – Always Beside You
Trusted supply. Transparent science.
Ausamics IverPure™
In recent years, several antiparasitic agents—namely ivermectin, fenbendazole, mebendazole, and albendazole—have attracted growing attention in cancer research. These compounds, originally developed to combat parasitic infections, are being explored for their potential to target cancer cell metabolism, disrupt microtubule formation, and inhibit survival signaling pathways.
